RGEN
Repligen Corporation
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$167.68
−1.14%Forward multiples
Based on analyst estimates
- P/E forward
- 74.19x
- P/E 2026E
- 81.69x
- P/E 2027E
- 64.23x
- P/E 2028E
- 49.26x
- P/S forward
- 10.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- 226.59x
- PEG TTM
- 1.11x
- Price / book
- 4.48x
- Price / sales
- 12.05x
- Price / cash flow
- 70.17x
Enterprise value
- Enterprise value
- $9.3B
- EV / sales
- 11.90x
- EV / EBITDA
- 76.69x
- EV / EBIT
- 143.09x
- Market cap
- $9.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026